You may not modify or otherwise make
derivative uses of the Site or the Site Content, or any portion thereof.
This license does not include any resale or commercial use of this site or its contents; any collection and use of any product listings, descriptions, or prices;
any derivative use of this site or its contents; any downloading or copying of account information for the benefit of another merchant; or any use of data mining, robots, or similar data gathering and extraction tools.
This license does not include any resale or commercial use of any IMDb Service or its contents or
any derivative use of this site or its contents.
Not exact matches
Without limiting the generality
of any terms or conditions set forth herein, in
using the
Site, you may not transmit or solicit: (a) any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information
of any kind, including images and language; (b) any message that constitutes, or encourages or incites conduct that would constitute, a criminal offense or gives rise to civil liability; or (c) any information, software or other material which violates or infringes upon the rights
of others, including material which is an invasion
of privacy or publicity rights or which is protected by copyright, trademark or other proprietary right, or
derivative works with respect thereto, without first obtaining permission from the owner or right holder.
You may not copy, store in any medium (including without limitation on any other website), modify, adapt, spider (i.e.
use a computer programme to collect or aggregate material from the
site), publish, distribute by any means (including without limitation via any peer - to - peer networks such as BitTorrent), prepare
derivative works from, broadcast, communicate to the public or transmit any part
of this
site or any
of the material contained in this
site or otherwise
use the content for any other purpose other than as explicitly permitted herein.
Except as expressly authorized in advance by MomLifeTV, you agree not to copy, distribute, transmit, display, perform or create
derivative works on the web
site or any
of the Materials, provided that, subject to your compliance with this Agreement, MomLifeTV grants you a limited, personal, revocable, non-transferable and non-sub-licensable license to (a) access the
site and the Materials via the Internet solely for purposes
of viewing such Materials and (b) to print out pages
of this
site for your personal, non-commercial
use.
agree to and do hereby grant Pregnancy After Loss Support and Lindsey Henke a nonexclusive, perpetual, irrevocable, worldwide, sub-licensable, transferrable, royalty - free right and license to
use, store, display, publish, transmit, transfer, distribute, reproduce, rearrange, edit, modify, aggregate, create
derivative works
of and publicly perform the content that you submit to the
Site for any purpose, in any form, medium, or technology now known or later developed.
By submitting user submissions to AAAS, however, you hereby grant AAAS a worldwide, irrevocable, non-exclusive, royalty - free, sub-licensable and transferable license to
use, reproduce, distribute, prepare
derivative works
of, display, perform and
use in any other manner that may be hereafter developed the user submissions in connection with the AAAS Web
site and AAAS's (and its successors» and affiliates») business, including without limitation for promoting and redistributing part or all
of the AAAS Web
site (and
derivative works thereof) in any media formats and through any media channels that exist now or may be developed.
If a
site started making
derivative works
of your material, even
using your photos in ads, or allowing third parties to do so without your permission, they would be violating the DMCA.
A, schematic representation
of serial p21waf1 / cip1 promoter — driven luciferase reporters
used in transactivation assay: p21 - Luc contains the 2.3 - kb full - length
of p21waf1 / cip1 promoter (from − 2,326 to +10 nucleotide related transcription start
site); its
derivatives (− 159 / +8) p21 - Luc, (− 123 / +8) p21 - Luc, (− 84 / +8) p21 - Luc, (− 76 / +8) p21 - Luc, (− 63 / +8) p21 - Luc, and (− 56 / +8) p21 - Luc contain a series
of deleted promoters
of p21waf1 / cip1.
(c) Personal
Use: Dr. Kimberley O'Brien grants you a limited, revocable, nonexclusive license to use this site solely for your own personal use and not for republication, distribution, assignment, sublicense, sale, preparation of derivative works, or other u
Use: Dr. Kimberley O'Brien grants you a limited, revocable, nonexclusive license to
use this site solely for your own personal use and not for republication, distribution, assignment, sublicense, sale, preparation of derivative works, or other u
use this
site solely for your own personal
use and not for republication, distribution, assignment, sublicense, sale, preparation of derivative works, or other u
use and not for republication, distribution, assignment, sublicense, sale, preparation
of derivative works, or other
useuse.
You also grant each user
of the
Site a non-exclusive license to access your User Content through the
Site, and to
use, reproduce, distribute, prepare derivative works of, display and perform User Content as permitted through the functionality of the Site and under these Terms of U
use, reproduce, distribute, prepare
derivative works
of, display and perform User Content as permitted through the functionality
of the
Site and under these Terms
of UseUse.
By submitting User Content to us, you hereby grant both us and our service providers a perpetual, worldwide, non-exclusive, royalty - free, sublicenseable and transferable license to
use, reproduce, distribute, prepare
derivative works
of, modify, display, and perform all or any portion
of the User Content in connection with the
Site and our (and our successors») business including without limitation for promoting and redistributing part or all
of the
Site (and
derivative works thereof) in any media formats and through any media channels.
Investment Analysis: As requested by state insurance regulators, the Capital Markets Bureau provides a number
of services --(1) Preliminary Investment Analysis and detailed Investment Analysis Reports; (2) Detailed Asset Reviews; (3)
Derivatives Use Plan Reviews; and (4) On -
Site Examination Support.
You agree that you will not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, create
derivative works from, frame in another Web page,
use on any other web
site, transfer or sell any information, software, lists
of users, databases or other lists, products or services provided through or obtained from the New Home Buyers Network Web Sites.
YOU MAY NOT COPY, REPRODUCE, DISTRIBUTE, PUBLISH, DISPLAY, PERFORM, MODIFY, CREATE
DERIVATIVE WORKS, TRANSMIT, OR IN ANY WAY EXPLOIT ANY CONTENT ON THE JTS
SITE, NOR MAY YOU DISTRIBUTE ANY PART
OF THIS CONTENT OVER ANY NETWORK, INCLUDING A LOCAL AREA NETWORK, SELL OR OFFER IT FOR SALE OR
USE, OR
USE SUCH CONTENT TO CONSTRUCT ANY KIND
OF DATABASE WITHOUT THE PRIOR WRITTEN PERMISSION
OF THE JAMAICA TOURIST BOARD.
Now I read that even if a piece is sold, the artist: 1) Isn't informed about shipping addresses; 2) Isn't assured that they have or will be paid; 3) Is responsible for paying the buyer's sales tax bill; 4) Presumably is required to forward sales tax funds to the buyer's state department
of revenue; 5) Has money / time invested in shipping a parcel to a potential buyer who may or may not return the art a week later (like a toaster oven); 6) Has language like the following within their user agreement: royalty - free, sub-licensable through multiple tiers, perpetual, irrevocable, worldwide right and license to
use, reproduce, distribute, modify, translate, create
derivative works from, publish, publicly perform and publicly display such User Content and any names, likenesses or trademarks depicted in such User Content, in any media now known or later developed, only for the purposes
of developing, promoting and providing the
Site.»
grant us a non-exclusive, royalty - free, sub-licensable through multiple tiers, perpetual, irrevocable, worldwide right and license to
use, reproduce, distribute, modify, translate, create
derivative works from, publish, publicly perform and publicly display such User Content and any names, likenesses or trademarks depicted in such User Content, in any media now known or later developed, only for the purposes
of developing, promoting and providing the
Site; ``
4.1 Where you are invited to submit any contribution to the
Site (including without limitation any text, graphics, video or audio) you are required by such submission to grant WRAP a perpetual, royalty - free, non-exclusive, sub-licenseable right and license to
use, reproduce, modify, adapt, publish, translate, create
derivative works from, distribute, perform, play, and exercise all copyright and publicity rights with respect to any such work worldwide and / or to incorporate it in other works in any media now known or later developed for the full term
of any rights that may exist in such content, consistent with privacy restrictions set forth in WRAP's Privacy Policy.
«By posting Third Party Content to any public area
of the
Site, you automatically grant, and you represent and warrant that you have the right to grant to [Forum] an irrevocable, perpetual, non-exclusive, fully paid, worldwide license to
use, copy, perform, display, and distribute said Content and to prepare
derivative works
of, or incorporate into other works, said Third Party Content, and to grant and authorize sublicenses (through multiple tiers)
of the foregoing.»
The decision by Mr. Justice Teare empowers lawyers for broker TFS
Derivatives to
use the social networking
site to track down former employee Fabio de Biase as part
of a suit brought against the company by investment manager AKO Capital.
In a landmark ruling issued Tuesday, a U.K. high court judge approved the
use of the social networking
site to track down a disgraced
derivatives broker being sued by the investment management company he duped.
With respect to such materials you submit or make available for inclusion on the
Site, you grant Policybazaar a perpetual, irrevocable, non-terminable, worldwide, royalty - free and non-exclusive license to
use, copy, distribute, publicly display, modify, create
derivative works, and sublicense such materials or any part
of such materials (as well as
use the name that you submit in connection with such submitted content).
Unless you enter into a written contract with Career Tips To Go for
use of content that states otherwise, you hereby grant Career Tips To Go the royalty - free, perpetual, irrevocable, worldwide, non-exclusive right and license to
use reproduce, modify, adapt, publish translate, create
derivative works from, distribute, perform and display all content, remarks, suggestions, ideas, graphics, or other information communicated to Career Tips To Go through this
site (together, the «Submission»), and to incorporate any Submission in other works in any form, media, or technology now known or later developed.
Without our prior written permission, you may not reproduce, distribute, modify, display, prepare
derivative works based on, re-post or otherwise
use the content
of this Web
Site, except that you may download one copy
of the material in temporal storage on one computer for your personal, non-commercial home viewing only, provided you do not delete or change any copyright, trademark, or other proprietary notices.
By submitting any content, you grant to NAR a nonexclusive, perpetual, irrevocable, worldwide, sublicensable, royalty - free license to
use, store, display, publish, transmit, transfer, distribute, reproduce, create
derivative works
of, and publicly perform such content for any purpose related to the
Site and the services provided through the
Site.
You may not distribute, reproduce, alter, modify, create
derivative works, license, display, publish,
use on any other website, transfer or sell any information, software, lists
of users, databases, products or services provided through or obtained from our
Site without the prior written permission
of the Company and / or the appropriate third party.